Moreover, lncRNA GAS5 could promote tumor progression by targeting TP53INP1 in hepatocellular carcinoma (Zhang et al., 2019) and the GAS5/TP53INP1 axis was also identified as gain interaction in our LIHC DysCeNet. The gene discussed is GAS5; the disease is hepatocellular carcinoma.